JS Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

JS Capital Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,200	Closed	-$309K	–	144
2021 Q1	$309K	Buy	+8,200	New	+$204K	0.02%	108

JS Capital Management's FPRX Position: Q2 2021 in Review

JS Capital Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 8,200 shares — an estimated $309K sold.

JS Capital Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $309K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

JS Capital Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
JS Capital Management sold 8,200 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $309K.
JS Capital Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
JS Capital Management's Five Prime Therapeutics, Inc. position peaked at $309K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on JS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.